Treace John T.

Insider Reports History

Reporting-owner location: Ponte Vedra, FL
Latest reporting-owner signature: /s/ Lisa Taylor as Attorney-in-fact for John Treace
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Treace John T.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

TREACE MEDICAL CONCEPTS, INC.

Security class: Common Stock
Shares / value: 7,348,439
Estimated value: $29,704,594
Report date: 11 Jun 2026
Price: $4.04
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

TREACE MEDICAL CONCEPTS, INC.

Security class: Common Stock
Shares / value: 1,839,063
Estimated value: $2,464,344
Report date: 10 Jun 2026
Price: $1.34
Ownership: As trustee of a trust

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

TREACE MEDICAL CONCEPTS, INC.

Security class: Common Stock
Shares / value: 1,605,000
Estimated value: $2,150,700
Report date: 10 Jun 2026
Price: $1.34
Ownership: By spouse

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

TREACE MEDICAL CONCEPTS, INC.

Security class: Common Stock
Shares / value: 1,471,250
Estimated value: $1,971,475
Report date: 10 Jun 2026
Price: $1.34
Ownership: By spouse as trustee of a trust

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

TREACE MEDICAL CONCEPTS, INC.

Security class: Common Stock
Shares / value: 408,816
Estimated value: $547,813
Report date: 10 Jun 2026
Price: $1.34
Ownership: As co-trustee of a trust

Insider Reports Filed by Treace John T.

4/A TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 10 Jun 2026
Transactions: 2
Transaction value: +$99,196
Accepted by SEC: 12 Jun 2026, 09:26
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 01 Jun 2026
Transactions: 1
Transaction value: +$177,915
Accepted by SEC: 01 Jun 2026, 16:38
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 26 May 2026
Transactions: 3
Transaction value: +$340,589
Accepted by SEC: 28 May 2026, 16:33
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 12 May 2026
Transactions: 3
Transaction value: +$375,505
Accepted by SEC: 14 May 2026, 17:33
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 08 Mar 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 Mar 2026, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 22 Jan 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 23 Jan 2026, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 10 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Jan 2026, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 08 Mar 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 Mar 2025, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 04 Mar 2025
Transactions: 1
Transaction value: +$524,064
Accepted by SEC: 04 Mar 2025, 18:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 22 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Jan 2025, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 10 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Jan 2025, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 17 Sep 2024
Transactions: 1
Transaction value: +$265,630
Accepted by SEC: 17 Sep 2024, 17:17
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 14 Aug 2024
Transactions: 1
Transaction value: +$510,314
Accepted by SEC: 15 Aug 2024, 17:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 11 Jun 2024
Transactions: 1
Transaction value: +$264,600
Accepted by SEC: 11 Jun 2024, 17:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 17 May 2024
Transactions: 1
Transaction value: +$556,170
Accepted by SEC: 20 May 2024, 16:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 14 May 2024
Transactions: 1
Transaction value: +$767,805
Accepted by SEC: 14 May 2024, 18:19
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 10 May 2024
Transactions: 2
Transaction value: +$1,370,370
Accepted by SEC: 13 May 2024, 18:07
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 08 Mar 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 12 Mar 2024, 21:55
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 10 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Jan 2024, 21:00
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 09 Mar 2023
Transactions: 3
Transaction value: -$50,651
Accepted by SEC: 10 Mar 2023, 20:00
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 21 Nov 2022
Transactions: 1
Transaction value: +$327,405
Accepted by SEC: 21 Nov 2022, 17:27
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 17 Nov 2022
Transactions: 1
Transaction value: +$216,714
Accepted by SEC: 17 Nov 2022, 16:55
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 01 Sep 2022
Transactions: 1
Transaction value: +$198,031
Accepted by SEC: 01 Sep 2022, 17:21
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 26 Aug 2022
Transactions: 1
Transaction value: +$450,342
Accepted by SEC: 29 Aug 2022, 09:00
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 23 Aug 2022
Transactions: 2
Transaction value: +$533,756
Accepted by SEC: 24 Aug 2022, 19:23
Role: Chief Executive Offer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 08 Mar 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 10 Mar 2022, 19:24
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 28 Dec 2021
Transactions: 2
Transaction value: -$388,118
Accepted by SEC: 30 Dec 2021, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 22 Dec 2021
Transactions: 3
Transaction value: -$1,365,270
Accepted by SEC: 27 Dec 2021, 19:10
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 20 Dec 2021
Transactions: 4
Transaction value: -$966,440
Accepted by SEC: 22 Dec 2021, 18:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 22 Nov 2021
Transactions: 6
Transaction value: -$2,946,489
Accepted by SEC: 24 Nov 2021, 19:48
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TMCI

TREACE MEDICAL CONCEPTS, INC.

Report period: 20 Oct 2021
Transactions: 11
Transaction value: -$3,555,011
Accepted by SEC: 22 Oct 2021, 21:36
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Treace John T.

Insider Reports Filed by Treace John T.